Your AI-Powered Market Intelligence

Friday, April 3, 2026
RSS

Dividends

The Index Inclusion Gambit: Why SpaceX's Nasdaq Preference Rewrites the Mega-Cap Playbook

SpaceX's potential Nasdaq listing highlights how index inclusion drives institutional access, reshaping exchan…

Catherine Walsh • Mar 11
Economy

Fed Holds at 3.50-3.75%: The Iran Premium Meets Labor Market Cracks — Here's the Trade

The Fed stands pat as oil volatility collides with softening jobs data. Watch these levels.

Tyler Brooks • Mar 11
Markets

TSX Outperforms as Resource Stocks Capitalize on Gold's Meteoric Rise

The TSX is beating US markets, driven by surging gold prices and strong materials sector performance. But inve…

Diana Kowalski • Mar 11
Invest with conviction.

Institutional-grade market intelligence and breaking analysis delivered before the opening bell. No noise. Just the data that moves the needle.

Earnings

Oracle's Cloud Alchemy: How the Database Dinosaur Learned to Print Money in the Sky

Oracle beats Q3 estimates with $4.58 EPS as cloud pivot accelerates, challenging AWS and Azure dominance in en…

Marcus Rivera • Mar 11, 2026
Dividends

Papa John's 19% Surge Highlights Private Equity's Appetite for Consumer Brand Premiums

Papa John's $47/share takeover bid reveals aggressive PE valuations, with Irth Capital paying 50% premiums for…

Sarah Chen • Mar 11, 2026
Markets

Geopolitical Jitters: How to Trade the Headlines Without Getting Burned

Geopolitical tensions sparked a wild trading session, revealing both risks and opportunities for nimble invest…

James McAllister • Mar 11, 2026
IPO & Market Structure

SpaceX's Nasdaq Strategy Could Reshape Mega-Cap IPO Landscape

SpaceX's potential Nasdaq listing with immediate $NDX inclusion could redefine how mega-cap IPOs access instit…

Catherine Walsh • Mar 11, 2026
Federal Reserve Policy

Fed Trapped at 3.50-3.75% as Iran Conflict Ignites Oil-Fueled Inflation Shock

The Fed's 3.50-3.75% rate hold faces stress tests as Middle East conflict drives energy volatility and sticky …

Tyler Brooks • Mar 11, 2026
Earnings Analysis

Vertex's Kidney Trial Win: Progress or Peril for Biotech Bulls?

Vertex Pharmaceuticals surged 4% on rare disease trial success, but investors should weigh pipeline risks agai…

Diana Kowalski • Mar 11, 2026
Earnings Analysis

Oracle's Cloud Ascendancy: Can It Weather the AI Storm?

Oracle's Q3 earnings beat underscores its successful cloud pivot, but can it maintain momentum amid intensifyi…

Marcus Rivera • Mar 11, 2026
Canadian Market Analysis

TSX Materials Rally Outpaces US Markets as Gold Hits Record Highs

Canadian equities outperform as materials and financials drive .GSPTSE to 33,270.65 while gold surges to $5,24…

Sarah Chen • Mar 11, 2026
US Market Analysis

While the Dow Panics, Tech Plays Defense: What the 800-Point Swing Really Tells Us

Markets shrug off geopolitical noise as tech resilience counters energy volatility. The divergence between Nas…

James McAllister • Mar 11, 2026